Daxor Corporation (DXR)

09:42 AM

Daxor (DXR) Highlights Key Heart Failure Study Results | DXR Sto - GuruFocus

09:42 AM

08:10 AM

Daxor Announces Duke University Study on Blood Volume - GlobeNewswire

08:10 AM

08:00 AM

Duke Research Reveals 40% of Heart Failure Patients Misdiagnosed with Anemia, Study Shows - Stock Titan

08:00 AM

May 13, 2025

Daxor (DXR) Expands Diagnostic Solutions Across U.S. Healthcare Systems | DXR Stock News - GuruFocus

May 13, 2025

May 13, 2025

Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems - GlobeNewswire

May 13, 2025

May 07, 2025

Daxor announces opening of new BVA program at Florida center - TipRanks

May 07, 2025

May 07, 2025

Daxor (DXR) Launches Advanced BVA Program in Tampa Bay Healthcare Center | DXR Stock News - GuruFocus

May 07, 2025

May 07, 2025

Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology - GlobeNewswire

May 07, 2025

May 07, 2025

Renaissance Technologies LLC Has $214,000 Stock Holdings in Daxor Co. (NASDAQ:DXR) - Defense World

May 07, 2025

May 07, 2025

Daxor announces expansion of BVA capabilities in three new hospitals - TipRanks

May 07, 2025

May 06, 2025

Daxor (DXR) Expands Blood Volume Analysis with New Hospital Part - GuruFocus

May 06, 2025

May 06, 2025

Daxor (DXR) Expands Blood Volume Analysis with New Hospital Partnerships | DXR Stock News - GuruFocus

May 06, 2025

May 06, 2025

Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance - GlobeNewswire

May 06, 2025

May 06, 2025

Daxor Expands Blood Volume Analysis Network: 3 Hospitals Choose Zero-Capital Diagnostic Solution - Stock Titan

May 06, 2025

May 05, 2025

NeuroMetrix (NASDAQ:NURO) and Daxor (NASDAQ:DXR) Head-To-Head Comparison - Defense World

May 05, 2025

May 02, 2025

Daxor Corporation Secures Funding for Blood Volume Analyzer Study - Medical Product Outsourcing

May 02, 2025

Apr 28, 2025

Daxor stock hits 52-week low at $6.83 amid market challenges - MSN

Apr 28, 2025

Apr 22, 2025

Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions - The Manila Times

Apr 22, 2025

Apr 22, 2025

Daxor Corporation to Exhibit at the 45th International - GlobeNewswire

Apr 22, 2025

Apr 22, 2025

Revolutionary Blood Volume Analysis: How Daxor's 98% Accurate Tech is Transforming Heart and Lung Care - Stock Titan

Apr 22, 2025

Apr 22, 2025

Daxor (NASDAQ:DXR) versus Integra LifeSciences (NASDAQ:IART) Head to Head Review - Defense World

Apr 22, 2025

Apr 21, 2025

(DXR) Trading Report - news.stocktradersdaily.com

Apr 21, 2025

Apr 18, 2025

Daxor Corporation to Showcase Innovative Blood Volume - GlobeNewswire

Apr 18, 2025

Apr 17, 2025

Daxor (DXR) to Exhibit at MedAxiom CV Transforum Spring'25 Conference | DXR Stock News - GuruFocus

Apr 17, 2025

Apr 17, 2025

Daxor to showcase blood volume analysis at Cardiovascular Transforum conference - TipRanks

Apr 17, 2025

Apr 17, 2025

Revolutionary Blood Volume Technology Slashes Mortality Rates by 82%Groundbreaking Clinical Results Unveiled - Stock Titan

Apr 17, 2025

Apr 15, 2025

Daxor announces new data at ACC on blood volume analysis - TipRanks

Apr 15, 2025

Apr 15, 2025

Daxor (DXR) Unveils Promising Heart Failure Study Results at ACC Conference | DXR Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic - GlobeNewswire

Apr 15, 2025

Apr 15, 2025

Breakthrough Heart Failure Study: Daxor BVA Test Doubles Patient Survival Rates - Stock Titan

Apr 15, 2025

Apr 11, 2025

Daxor (DXR) Submits Next-Gen Blood Analyzer to FDA for Approval - GuruFocus

Apr 11, 2025

Apr 10, 2025

Daxor submits new blood volume analyzer to FDA By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer - marketscreener.com

Apr 10, 2025

Apr 10, 2025

Daxor submits new blood volume analyzer to FDA - Investing.com

Apr 10, 2025

Apr 10, 2025

Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer - GlobeNewswire

Apr 10, 2025

Apr 10, 2025

Revolutionary Blood Volume Analyzer With Military Backing Advances Toward FDA Green Light - Stock Titan

Apr 10, 2025

Apr 07, 2025

CEO’s Bold Move: Major Investment in Daxor Stock - TipRanks

Apr 07, 2025

Apr 07, 2025

Daxor CEO Michael Feldschuh purchases over $16,000 in stock By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Daxor CEO Michael Feldschuh purchases over $16,000 in stock - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

DAXOR CEO Michael Richard Feldschuh Buys 2,063 Shares - TradingView

Apr 07, 2025

Apr 05, 2025

Where are the Opportunities in (DXR) - news.stocktradersdaily.com

Apr 05, 2025

Apr 04, 2025

Daxor Corporation (NASDAQ:DXR) Q4 2024 Earnings Call Transcript - MSN

Apr 04, 2025

Apr 04, 2025

Daxor (NYSEAMERICAN:DXR) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World

Apr 04, 2025

Apr 02, 2025

Daxor announces new data from Duke University on BVA at ACC - TipRanks

Apr 02, 2025

Apr 02, 2025

Daxor’s BVA technology gains traction at cardiology event - Investing.com

Apr 02, 2025

Apr 02, 2025

Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo - GlobeNewswire

Apr 02, 2025

Apr 02, 2025

Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology's 74th Annual Scientific Session and Expo - The Manila Times

Apr 02, 2025

Apr 02, 2025

Duke Research Reveals Why Daxor's Blood Test Outperforms Traditional Heart Failure Methods - Stock Titan

Apr 02, 2025

Mar 29, 2025

Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks - GlobeNewswire

Mar 29, 2025

Mar 28, 2025

Daxor Expands to 3 New Locations in New Jersey, Midwest - MarketScreener

Mar 28, 2025

Mar 28, 2025

Breakthrough Blood Volume Tech With 98% Accuracy Gains Major Healthcare Adoption - Stock Titan

Mar 28, 2025

Mar 27, 2025

Daxor CEO Michael Feldschuh purchases $8,130 in company shares - Investing.com

Mar 27, 2025

Mar 27, 2025

Daxor CEO Michael Feldschuh purchases $8,130 in company shares By Investing.com - Investing.com UK

Mar 27, 2025

Mar 20, 2025

Daxor CEO Feldschuh buys shares worth $5,273 By Investing.com - Investing.com Canada

Mar 20, 2025